Pasco et al. [54] reported that high sensitivity CRP (hsCRP)—a more sensitive measure of inflammation—is an independent risk factor of depression and its elevated levels can predict de novo MDD occurrence. This evidence concerns the gene CRP and depressive symptom measurement.